GNMX
Northern Trust’s Aevi Genomic Medicine, Inc. GNMX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-50,541
| Closed | -$7K | – | 4321 |
|
|
2019
Q4 | $7K | Hold |
50,541
| – | – | ﹤0.01% | 4217 |
|
|
2019
Q3 | $8K | Hold |
50,541
| – | – | ﹤0.01% | 4200 |
|
|
2019
Q2 | $8K | Hold |
50,541
| – | – | ﹤0.01% | 4219 |
|
|
2019
Q1 | $10K | Hold |
50,541
| – | – | ﹤0.01% | 4171 |
|
|
2018
Q4 | $35K | Hold |
50,541
| – | – | ﹤0.01% | 4108 |
|
|
2018
Q3 | $62K | Hold |
50,541
| – | – | ﹤0.01% | 4109 |
|
|
2018
Q2 | $56K | Hold |
50,541
| – | – | ﹤0.01% | 4111 |
|
|
2018
Q1 | $102K | Sell |
50,541
-4,833
| -9% | -$9.75K | ﹤0.01% | 3973 |
|
|
2017
Q4 | $66K | Sell |
55,374
-5,036
| -8% | -$6K | ﹤0.01% | 4039 |
|
|
2017
Q3 | $76K | Sell |
60,410
-24
| -0% | -$30 | ﹤0.01% | 4008 |
|
|
2017
Q2 | $80K | Sell |
60,434
-240,583
| -80% | -$318K | ﹤0.01% | 4016 |
|
|
2017
Q1 | $559K | Buy |
301,017
+1,740
| +0.6% | +$3.23K | ﹤0.01% | 3502 |
|
|
2016
Q4 | $1.55M | Buy |
299,277
+22,358
| +8% | +$116K | ﹤0.01% | 3215 |
|
|
2016
Q3 | $1.54M | Buy |
276,919
+457
| +0.2% | +$2.55K | ﹤0.01% | 3186 |
|
|
2016
Q2 | $1.53M | Buy |
276,462
+28,155
| +11% | +$156K | ﹤0.01% | 3170 |
|
|
2016
Q1 | $1.09M | Buy |
248,307
+16,696
| +7% | +$73.5K | ﹤0.01% | 3226 |
|
|
2015
Q4 | $1.39M | Buy |
231,611
+51,725
| +29% | +$311K | ﹤0.01% | 3208 |
|
|
2015
Q3 | $1.41M | Buy |
179,886
+126,957
| +240% | +$993K | ﹤0.01% | 3213 |
|
|
2015
Q2 | $324K | Buy |
52,929
+23,452
| +80% | +$144K | ﹤0.01% | 3672 |
|
|
2015
Q1 | $238K | Buy |
29,477
+1,861
| +7% | +$15K | ﹤0.01% | 3810 |
|
|
2014
Q4 | $140K | Hold |
27,616
| – | – | ﹤0.01% | 3901 |
|
|
2014
Q3 | $143K | Sell |
27,616
-87
| -0.3% | -$450 | ﹤0.01% | 3934 |
|
|
2014
Q2 | $215K | Buy |
27,703
+56
| +0.2% | +$435 | ﹤0.01% | 3840 |
|
|
2014
Q1 | $193K | Buy |
27,647
+2,708
| +11% | +$18.9K | ﹤0.01% | 3798 |
|
|
2013
Q4 | $149K | Buy |
24,939
+8,812
| +55% | +$52.6K | ﹤0.01% | 3788 |
|
|
2013
Q3 | $126K | Buy |
16,127
+590
| +4% | +$4.61K | ﹤0.01% | 3774 |
|
|
2013
Q2 | $59K | Buy |
+15,537
| New | +$59K | ﹤0.01% | 3905 |
|